These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. Chen W; Silverman DH; Delaloye S; Czernin J; Kamdar N; Pope W; Satyamurthy N; Schiepers C; Cloughesy T J Nucl Med; 2006 Jun; 47(6):904-11. PubMed ID: 16741298 [TBL] [Abstract][Full Text] [Related]
5. Corticostriatal covariance patterns of 6-[18F]fluoro-L-dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease. Kaasinen V; Maguire RP; Hundemer HP; Leenders KL J Neurol; 2006 Mar; 253(3):340-8. PubMed ID: 16222426 [TBL] [Abstract][Full Text] [Related]
6. Striatal dopamine during sensorial stimulations: a [18F]FDOPA PET study in human and cats. Hassoun W; Thobois S; Ginovart N; Garcia-Larrea L; Cavorsin ML; Guillouet S; Bonnefoi F; Costes N; Lavenne F; Martin JP; Broussolle E; Leviel V Neurosci Lett; 2005 Jul 22-29; 383(1-2):63-7. PubMed ID: 15936513 [TBL] [Abstract][Full Text] [Related]
7. Estimation of patient dose in (18)F-FDG and (18)F-FDOPA PET/CT examinations. Kaushik A; Jaimini A; Tripathi M; D'Souza M; Sharma R; Mishra AK; Mondal A; Dwarakanath BS J Cancer Res Ther; 2013; 9(3):477-83. PubMed ID: 24125986 [TBL] [Abstract][Full Text] [Related]
8. Striatal dopa and glucose metabolism in PD patients with freezing of gait. Bartels AL; de Jong BM; Giladi N; Schaafsma JD; Maguire RP; Veenma L; Pruim J; Balash Y; Youdim MB; Leenders KL Mov Disord; 2006 Sep; 21(9):1326-32. PubMed ID: 16721756 [TBL] [Abstract][Full Text] [Related]
9. Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction. Ruottinen HM; Rinne JO; Oikonen VJ; Bergman JR; Haaparanta MT; Solin OH; Ruotsalainen UH; Rinne UK Synapse; 1997 Dec; 27(4):336-46. PubMed ID: 9372556 [TBL] [Abstract][Full Text] [Related]
10. Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies. Nagano-Saito A; Kato T; Arahata Y; Washimi Y; Nakamura A; Abe Y; Yamada T; Iwai K; Hatano K; Kawasumi Y; Kachi T; Dagher A; Ito K Neuroimage; 2004 Jun; 22(2):553-61. PubMed ID: 15193583 [TBL] [Abstract][Full Text] [Related]
11. Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuli. Siessmeier T; Kienast T; Wrase J; Larsen JL; Braus DF; Smolka MN; Buchholz HG; Schreckenberger M; Rösch F; Cumming P; Mann K; Bartenstein P; Heinz A Eur J Neurosci; 2006 Jul; 24(1):305-13. PubMed ID: 16882026 [TBL] [Abstract][Full Text] [Related]
13. Nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET. Tissingh G; Bergmans P; Winogrodzka A; Stoof JC; Wolters EC; Booij J; Van Royen EA J Nucl Med; 1997 Aug; 38(8):1271-2. PubMed ID: 9255164 [No Abstract] [Full Text] [Related]
14. Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA. Cropley VL; Fujita M; Bara-Jimenez W; Brown AK; Zhang XY; Sangare J; Herscovitch P; Pike VW; Hallett M; Nathan PJ; Innis RB Psychiatry Res; 2008 Jul; 163(2):171-82. PubMed ID: 18504119 [TBL] [Abstract][Full Text] [Related]
15. Can (18)F-FDOPA PET/CT predict survival in patients with suspected recurrent glioma? A prospective study. Karunanithi S; Sharma P; Kumar A; Gupta DK; Khangembam BC; Ballal S; Kumar R; Kumar R; Bal C Eur J Radiol; 2014 Jan; 83(1):219-25. PubMed ID: 24191944 [TBL] [Abstract][Full Text] [Related]
16. Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: a two-year follow-up study. Brück A; Aalto S; Nurmi E; Vahlberg T; Bergman J; Rinne JO Mov Disord; 2006 Jul; 21(7):958-63. PubMed ID: 16550545 [TBL] [Abstract][Full Text] [Related]
17. [(18)F]FDOPA and [(18)F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease. Rinne OJ; Nurmi E; Ruottinen HM; Bergman J; Eskola O; Solin O Synapse; 2001 Jun; 40(3):193-200. PubMed ID: 11304757 [TBL] [Abstract][Full Text] [Related]
18. Comparison of [18F]FDOPA, [18F]FMT and [18F]FECNT for imaging dopaminergic neurotransmission in mice. Honer M; Hengerer B; Blagoev M; Hintermann S; Waldmeier P; Schubiger PA; Ametamey SM Nucl Med Biol; 2006 Jul; 33(5):607-14. PubMed ID: 16843835 [TBL] [Abstract][Full Text] [Related]
19. The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas. Taïeb D; Tessonnier L; Sebag F; Niccoli-Sire P; Morange I; Colavolpe C; De Micco C; Barlier A; Palazzo FF; Henry JF; Mundler O Clin Endocrinol (Oxf); 2008 Oct; 69(4):580-6. PubMed ID: 18394015 [TBL] [Abstract][Full Text] [Related]